Health system implications of direct-to-consumer personal genome testing

Public Health Genomics

Volumn 14, Issue 1, 2011, Pages 53-58

  McGuire, Amy L ^a   Burke, Wylie ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Consumer safety; direct to consumer; DNA test kit; Personal genome testing

Indexed keywords

ARTICLE; CONSUMER; CONSUMER HEALTH INFORMATION; GENETIC RISK; GENETIC SCREENING; GENOME ANALYSIS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; PHYSICIAN; PRIORITY JOURNAL; RELIABILITY;

EID: 78650414687     PISSN: 16624246     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321962     Document Type: Article

References (34)

1. Hamilton A: Time's Best Inventions of 2008. Time Magazine, Oct 29, 2008. www.time.com/time/specials/packages/article/0,28804,1852747-1854493-1854113,00. html.
2. Collins F: The language of life: DNA and the revolution in personalized medicine New York, HarperCollins, 2010.
3. Hogarth S, Javitt G, Melzer D: The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Ann Rev Genomics Hum Genet 2008; 9: 161-182.
4. Hunter DJ, Khoury MJ, Drazen JM: Letting the genome out of the bottle: will we get our wish? N Engl J Med 2008; 358: 105-107.
5. Federal Trade Commission: At-home genetic tests: a healthy dose of skepticism may be the best prescription. 2006. www.ftc.gov/ bcp/edu/pubs/ consumer/health/hea02.shtm (accessed October 15, 2010).
6. Kutz G: Nutrigenetic testing: tests purchased from four web sites mislead consumers. Report No: GAO-06-977T. Washington, US Government Accountability Office, 2006, p 27.
7. Stein R: Fears surround over-the-counter genetic tests. The Washington Post, May 11, 2010. www.msnbc.msn.com/id/37076766/ns/health-more-health-news (accessed October 15, 2010).
8. Marietta C, McGuire AL: Currents in contemporary ethics. Direct-to-consumer genetic testing: is it the practice of medicine? J Law Med Ethics 2009; 37: 369-364.
9. www.navienics.com 10 23andMe: Terms of service. 2007. www. 23andme.com/about/tos (accessed October 15, 2010).
10. Prainsack B, Reardon J, Hindmarsh R, Gottweis H, Naue U, Lunshof J. Personalized genomes: misdirected precaution. Nature 2008; 465: 34-35.
11. The Oprah Winfrey Show: Headline-making news. Oprah.com, November 14, 2008. www.oprah.com/oprahshow/Live-with- Rob-Lowe -Mel I s s a-Ether id ge-a nd- More/9#slide (accessed October 15, 2010).
12. McBride CM, Bowen D, Brody LC, Condit CM, Croyle RT, Gwinn M, Khoury MJ, Koehly LM, Korf BR, Marteau TM, McLeroy K, Patrick K, Valente TW: Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med 2010; 38: 556-565.
13. Kutz G: Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. Report No: GAO-10- 847T. Washington, US Government Accountability Office, 2010, p 33.
14. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG: Social networkers' attitudes toward direct- to-consumer personal genome testing. Am J Bioeth 2009; 9: 3-10.
15. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ: A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health inventions. Am J Hum Genet 2008; 82: 593-599.
16. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al.: Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
17. Fleming N: Rival genetic tests leave buyers confused. The Sunday Times, September 2, 2008. www.timesonline.co.uk/tol/news/uk/ science/article4692891.ece (accessed October 15, 2010).
18. US Department of Health and Human Services, Centers for Medicare and Medicaid Services: Regulations and guidance: clinical laboratory improvement amendments. 2010. www.cms.gov/CLIA/09-CLIA-Regulations-and-Federal-Register- Documents. asp (accessed October 15, 2010).
19. Sterling R, Adams S, McLeod H, Evans JP: Assessing claims, disclaimers, and performance of personal genomic services; in Caulfield T, Knoppers BM (co-chairs): Proceedings of The Age of Personalized Genomics: 5th International DNA Sampling Conference. Banff, 2010, p 106.
20. US Food and Drug Administration: Letters to industry. www.fda.gov/MedicalDevices/ ResourcesforYou/Industry/ucm111104.htm
21. McGuire AL, Evans BJ, Caulfield T, Burke W: Regulating direct-to-consumer personal genome testing. Science 2010; in press.
22. McGuire AL, Burke W: An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA 2008; 300: 2669-2671.
23. American College of Medical Genetics: Statement on direct-to-consumer genetic testing. 2007. www.acmg.net/AM/Template.cfm?Section=Search2§ion= Home-Page-News-Releases&template=/CM/ContentDisplay.cfm&ContentFileID= 144 (accessed October 15, 2010).
24. American Medical Association: Direct-toconsumer genetic testing. www.ama-assn. org/ama1/pub/upload/mm/464/dtc-genetictest. pdf (accessed October 15, 2010).
25. 23andMe: Consent document. 2007. www. 23andme.com/about/consent (accessed October 15, 2010).
26. Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, et al: The scientific foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention Multidisciplinary Workshop. Genet Med 2009; 11: 559-567.
27. Lai-Goldman M, Faruki H: Abacavir hypersensitivity: a model system for pharmacogenetic test adoption. Genet Med 2008; 10(12):874-878.
28. Longo R, D'Andrea M, Sarmiento R, Gasparini G: Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab. Expert Opin Investig Drugs 2010, 19(suppl 1):S41-S50.
29. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group: Recommendation from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet Med 2007; 9: 819-825.
30. Adami HO: The prostate cancer pseudoepidemic. Acta Oncol 2010; 49: 298-304.
31. Farley TA: Reforming health care or reforming health? Am J Public Health 2009; 99: 588-590.
32. Deyo RA: Cascade effects of medical technology. Annu Rev Public Health 2002; 23: 23-44.
33. Khoury MJ, Rich EC, Randhawa G, Teutsch SM, Niederhuber J: Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine. Genet Med 2009; 11: 707-711.
34. Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health: Systems for research and evaluation for translating genome-based discoveries for health. Workshop summary. Washington, National Academic Press, 2009.